Maravai LifeSciences Holdings, Inc. (MRVI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 897.59M |
| Enterprise Value | 716.28M |
| P/E Ratio | -7.17 |
| PEG Ratio | -0.3 |
| Price/Sales Ratio | 13.36 |
| Price/Book Ratio | 3.6 |
| Enterprise/Revenue | 13.87 |
| Enterprise/EBITDA | -27.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.51 |
| Operating Margin | 0.22 |
| Return On Assets | -0.15 |
| Return On Equity | -0.45 |
| Revenue | 185.74M |
| Revenue/Share | 1.4 |
| Gross Profit | 33.39M |
| EBITDA | -147.11M |
| Net Income | -130.77M |
| Diluted EPS | -0.91 |
| Total Cash | 165.92M |
| Total Cash/Share | 1.13 |
| Total Debt | 270.88M |
| Total Debt/Equity | 1.28 |
| Current Ratio | 5.91 |
| Book Value Per Share | 2.52 |
| 52-Week Change | 146.45 |
| 52-Week High | 5.32 |
| 52-Week Low | 1.99 |
| Moving Average 50 Days | 4.23 |
| Moving Average 200 Days | 3.51 |
| Average Volume | 2.53M |
| Shares Outstanding | 145.1M |
| % Held by Institutions | 83.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |